EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma

Dongdong Yin, Yinci Zhang, Hui Li, Longqiang Cheng iD

The Clinical Respiratory Journal · 2023

DOI: 10.1111/crj.13717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2023. Verfasst von Dongdong Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital (Huainan First People's Hospital), Anhui University of Science and Technology, Huainan, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, University Natural Science Research Project of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) have different pathological and clinical features, they may share common driver genes. It was found that lipid levels can be used for early diagnosis of NSCLC; however, the relationship between driver genes and genes regulating lipid metabolism and their relationship with patient prognosis needs further investigation.

Methods

Genes whose expression was up‐ or down‐regulated in both LUAD and LUSC were identified using the GEO database. Online tools like GEPIA 2, PrognoScan, UALCAN, and TIMER2.0 were used to investigate the association of these gene expressions with the patient's prognosis and lipid regulatory genes. The association between clinical lipid levels and the risk of LUAD and LUSC was analyzed by using a multiple logistic regression model.

Results

Topoisomerase II alpha ( TOP2A ) and alcohol dehydrogenase 1B ( ADH1B ) were identified as the only genes up‐ and down‐regulated in both LUAD and LUSC. TOP2A and ADH1B expression levels significantly correlated with the patient's gender, age, individual cancer stage, histological subtype, nodal metastasis status, and TP53 mutation status. Additionally, only LUAD patients with higher TOP2A or lower ADH1B expressions displayed poor overall and relapse‐free survival rates. Moreover, TOP2A levels exhibited a negative correlation with adipose triglyceride lipase ( ATGL ) and ATP‐binding cassette transporter A1 ( ABCA1 ) in both LUAD and LUSC. However, ADH1B showed inverse associations with the above‐mentioned genes when compared to TOP2A expressions in both LUAD and LUSC. Furthermore, elevated triglyceride (OR = 1.59; 95% CI = 1.01 to 2.49; P < 0.05) and total cholesterol (OR = 2.45; 95% CI = 1.08 to 5.57; P < 0.05) levels might increase the risk of LUAD.

Conclusions

TOP2A and ADH1B can be used as diagnostic markers for LUAD and LUSC, but only as independent prognostic factors for LUAD, and may be involved in lipid metabolism in LUAD patients but not in LUSC. Thus, combining genetic diagnostics with lipid panel tests might be an effective method for an early diagnosis and improved prognosis of LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellLung NeoplasmsHumansAlcohol DehydrogenaseDNA Topoisomerases, Type IILipidsNeoplasm Recurrence, LocalPrognosisPoly-ADP-Ribose Binding Proteins

Stichwörter der Autor:innen

alcohol dehydrogenase 1Blung adenocarcinomalung squamous cell carcinomatopoisomerase II alphatotal cholesteroltriglyceride

Substanzen

Alcohol DehydrogenaseDNA Topoisomerases, Type IILipidsADH1B protein, humanTOP2A protein, humanPoly-ADP-Ribose Binding Proteins

Autor:innen und Institutionen

  • First Affiliated Hospital (Huainan First People's Hospital), Anhui University of Science and Technology, Huainan, China.

ORCID-Profile: Longqiang Cheng

Förderung

  • CSRD VA
  • University Natural Science Research Project of Anhui Province

Zitieren

APA

Yin, D., Zhang, Y., Li, H., & Cheng, L. (2023). Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13717

Vancouver

Yin D, Zhang Y, Li H, Cheng L. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. The Clinical Respiratory Journal. 2023. doi:10.1111/crj.13717

BibTeX
@article{Yin2023,
  author = {Yin, Dongdong and Zhang, Yinci and Li, Hui and Cheng, Longqiang},
  title = {Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma},
  journal = {The Clinical Respiratory Journal},
  year = {2023},
  doi = {10.1111/crj.13717}
}
Kostenlos starten →